Overall rank by patents
#3,224
Across all tracked assignees
USPTO PatentsView assignee record - 116 granted patents across 52 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS).
The verdict
DOW holds 116 US patents across 52 technology areas, rank #3,224 of 50,000 tracked assignees.
DOW TRAY Co., Ltd. has been granted 116 US utility patents between 2019 and 2025, placing DOW TRAY Co., Ltd. at rank #3,224 across all assignees tracked by PlainPatent. This portfolio spans 52 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in C08G (MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS). As a Foreign Corporation, DOW TRAY Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, DOW sits between Arena Pharmaceuticals, Inc. (116 patents, rank #3,220) and Hasbro, Inc. (116 patents, rank #3,228) - the closest US assignees by grant volume. The composite Innovation Score of 59.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 108 grants, compared with 8 in the 2015–2019 window, a +1250% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. DOW TRAY Co., Ltd.'s 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 52 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark DOW TRAY Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Arena Pharmaceuticals, Inc.
116 patents
BIOTRONIK AG
116 patents
BOOZ ALLEN HAMILTON INC.
116 patents
CHINA MOBILE COMMUNICATION CO., LTD RESEARCH INSTITUTE
116 patents
FUJIFILM HEALTHCARE CORPORATION
116 patents
HITACHI MEDICAL CORPORATION
116 patents
Hach Company
116 patents
Hasbro, Inc.
116 patents
DOW TRAY CO., LTD.
116 patents
What this shows DOW holds 116 patents at rank #3,224, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,224 in granted patent volume.
Other assignees with the most granted patents in DOW's primary technology class.
DOW's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 8 | 6.9% |
| 2020 | 18 | 15.5% |
| 2021 | 14 | 12.1% |
| 2022 | 14 | 12.1% |
| 2023 | 14 | 12.1% |
| 2024 | 32 | 27.6% |
| 2025 | 16 | 13.8% |
Top 15 of 52 technology areas
Overall rank by patents
#3,224
Across all tracked assignees
59.8 out of 100
How to use this portfolio
DOW's 116 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.